Roboculator
Online CalculatorsCategoriesDate & EventsNews
Get Started
Online CalculatorsCategoriesDate & EventsNewsGet Started
Roboculator

Smart calculators for every challenge. Free, fast, and private.

Categories

  • Finance
  • Health
  • Math
  • Construction
  • Conversion
  • Everyday Life

Popular Tools

  • Date & Events
  • Loan Calculator
  • BMI Calculator
  • Percentage Calc
  • Latest News
  • Search All

Resources

  • Glossary
  • Topic Tags
  • News & Insights

Company

  • About
  • Contact

Legal

  • Privacy Policy
  • Terms of Service
  • Editorial Policy
  • Disclaimer
© 2026 Roboculator. All rights reserved.
Roboculator

roboculator.com

  1. Home
  2. /Health
  3. /Pulmonology & Respiratory Calculators
  4. /BODE Index (COPD)

BODE Index (COPD)

Last updated: April 5, 2026

The BODE Index Calculator scores COPD severity across four domains — BMI, airflow obstruction, dyspnea, and exercise capacity — to predict 4-year mortality. Scores 0–2 carry roughly 20% 4-year mortality; scores 7–10 carry roughly 80%. Educational tool — COPD management requires physician evaluation.

Calculator

Results

BODE Index

2

BODE Quartile

1

Estimated 4-Year Mortality

15

%

BMI Points

0

FEV1 Points

1

Dyspnea Points

1

Walk Distance Points

0

Results

BODE Index

2

BODE Quartile

1

Estimated 4-Year Mortality

15

%

BMI Points

0

FEV1 Points

1

Dyspnea Points

1

Walk Distance Points

0

In This Guide

  1. 01BODE Index Scoring
  2. 02BODE Score and Prognosis (Celli et al. 2004)
  3. 03MRC Dyspnea Scale Reference
  4. 04What a High BODE Score Should Trigger Clinically

FEV₁ alone is a poor predictor of COPD prognosis because it captures only one dimension of a disease that affects body composition, exercise capacity, and respiratory symptoms simultaneously. The BODE Index (Celli et al., 2004) integrates all four dimensions into a single 10-point score that predicts 4-year mortality better than FEV₁ alone — and guides clinical decisions about pulmonary rehabilitation, specialist referral, and advance care planning. The BODE Index calculator provides immediate scoring and prognostic interpretation. All management decisions require physician evaluation.

BODE Index Scoring

Each component scored 0–3; maximum total = 10:

  • B — BMI: BMI above 21 = 0; BMI ≤21 = 1 (low BMI signals nutritional depletion, a strong negative prognostic indicator in COPD)
  • O — Obstruction (FEV₁% predicted): ≥65% = 0; 50–64% = 1; 36–49% = 2; ≤35% = 3
  • D — Dyspnea (MRC grade): 0–1 = 0; 2 = 1; 3 = 2; 4 = 3
  • E — Exercise (6-minute walk distance): ≥350 m = 0; 250–349 m = 1; 150–249 m = 2; below 150 m = 3

Use this online calculator for immediate scoring. The APACHE II calculator provides complementary critical illness severity scoring.

BODE Score and Prognosis (Celli et al. 2004)

  • Score 0–2: ~20% 4-year mortality — lowest risk; lifestyle and pharmacological management focus
  • Score 3–4: ~30% 4-year mortality — moderate risk; pulmonary rehabilitation discussion
  • Score 5–6: ~40–50% 4-year mortality — high risk; pulmonary rehabilitation referral strongly indicated
  • Score 7–10: ~80% 4-year mortality — very high risk; lung transplant evaluation for appropriate candidates; advance care planning

BODE predicts both all-cause and respiratory mortality significantly better than FEV₁% alone (AUC 0.74 vs. 0.65). A BODE reduction of ≥1 point with treatment (especially improved 6MWD from pulmonary rehab) correlates with improved survival. The respiratory calculators provide the complete COPD assessment toolkit.

MRC Dyspnea Scale Reference

  • Grade 0: breathless only with strenuous exercise
  • Grade 1: breathless hurrying on level ground or slight incline
  • Grade 2: walks slower than peers on level ground or stops for breath on level walking at own pace
  • Grade 3: stops for breath after 100 meters or a few minutes on level ground
  • Grade 4: too breathless to leave house; breathless dressing/undressing

What a High BODE Score Should Trigger Clinically

BODE 5–6+: pulmonary rehabilitation referral (strongest evidence-based intervention for COPD — improves 6MWD, dyspnea, and quality of life); review of pharmacological regimen (LAMA + LABA ± ICS); nutritional assessment if BMI ≤21; formal advance care planning discussion. BODE 7–10: lung transplant evaluation where appropriate (typically age below 65, non-smoking, adequate cardiac/renal reserve, FEV₁ below 25%); maximize symptom management; ensure palliative care integration. Serial BODE scoring every 3–6 months tracks disease trajectory. All management decisions require physician evaluation.

Visual Analysis

How It Works

Score each BODE domain: BMI (>21=0; ≤21=1); FEV₁% predicted (≥65=0; 50-64=1; 36-49=2; ≤35=3); MRC dyspnea grade (0-1=0; 2=1; 3=2; 4=3); 6-minute walk distance in meters (≥350=0; 250-349=1; 150-249=2; <150=3). Total = 0–10. Higher score = worse prognosis. Educational tool — COPD management requires physician evaluation.

Understanding Your Results

Quartile 1 (0-2): ~15% 4-year mortality. Q2 (3-4): ~30%. Q3 (5-6): ~40%, consider transplant evaluation. Q4 (7-10): ~80%, urgent intervention needed.

Worked Examples

Moderate COPD (Q2)

Inputs

bmi26
fev1 pct55
mmrc2
walk distance320

Results

bode score3
quartileQuartile 2 (3-4)
four year mortality~30%

BODE 3: BMI normal (0), FEV1 55% (1), mMRC 2 (1), walk 320m (1).

Severe COPD (Q4)

Inputs

bmi19
fev1 pct28
mmrc4
walk distance100

Results

bode score10
quartileQuartile 4 (7-10)
four year mortality~80%

BODE 10 (max): all domains severely impaired, transplant evaluation urgent.

Frequently Asked Questions

The BODE Index is a multidimensional COPD severity and prognosis score combining four parameters: Body mass index (nutritional status); airflow Obstruction (FEV₁% predicted); Dyspnea (MRC scale); and Exercise capacity (6-minute walk distance). Each domain is scored 0–3 and summed for a total of 0–10. BODE was developed to improve on FEV₁-only staging, which misses the systemic consequences of COPD. Larger validation studies confirmed BODE's superiority over FEV₁ alone for predicting 4-year all-cause and respiratory mortality. This is an educational tool — clinical use requires physician evaluation.
BODE scores of 5–6 indicate high risk with approximately 40–50% 4-year mortality; scores of 7–10 indicate very high risk with approximately 80% 4-year mortality. These upper quartiles represent patients who have both severe airflow limitation (FEV₁ ≤49%) and multiple additional impairments: markedly reduced exercise capacity (6MWD below 250 m), significant dyspnea (MRC 3–4), and often poor nutritional status (BMI ≤21). At BODE 7–10, pulmonary transplant evaluation is appropriate for suitable candidates, and advance care planning discussions should be initiated. All clinical decisions require physician evaluation.
The 6-minute walk test (6MWT) measures the maximum distance walked on level ground in 6 minutes. Standard ATS protocol: 30-meter (100-foot) straight hallway; patient walks at their own pace (as fast as comfortably possible); standardized encouragement phrases at 1-minute intervals; rest periods allowed but timer continues; measure distance at exactly 6 minutes. Normal ranges in healthy adults 60–80 years: approximately 400–700 m depending on age, sex, and height. COPD BODE thresholds: ≥350 m (0 points); 250–349 m (1 point); 150–249 m (2 points); below 150 m (3 points). Test must be administered by trained clinical staff under appropriate supervision.
Yes — pulmonary rehabilitation consistently reduces BODE scores, primarily by improving 6-minute walk distance and reducing dyspnea. Meta-analyses of randomized controlled trials show average BODE reductions of 1.0–1.5 points following 12–24 week pulmonary rehabilitation programs. A BODE reduction of ≥1 point is associated with improved survival. Long-acting bronchodilators (LAMA, LABA) improve FEV₁% and dyspnea subscores. Nutritional supplementation improves BMI in depleted patients. Pulmonary rehabilitation is the highest-evidence intervention for improving BODE score and is recommended by GOLD for all COPD patients with significant disability regardless of GOLD stage. All treatment decisions require physician evaluation.
GOLD staging classifies COPD using FEV₁% alone (GOLD 1–4) and more recently adds symptom burden and exacerbation history (ABCD groups). GOLD is practical for pharmacological management decisions. BODE provides superior mortality prediction (AUC 0.74 vs. 0.65 for FEV₁) because it captures functional impairment dimensions FEV₁ misses. A patient can be GOLD 2 (moderate, FEV₁ 50–79%) with a high BODE score (5–6) due to poor exercise tolerance and low BMI — indicating much higher mortality risk than GOLD stage suggests. Clinicians often use both: GOLD for pharmacological decisions; BODE for prognosis, pulmonary rehabilitation prioritization, and transplant candidacy assessment.
The International Society for Heart and Lung Transplantation (ISHLT) guidelines recommend listing evaluation for COPD patients with: BODE index 7–10; FEV₁ below 15–20% predicted; hypercapnia (PaCO₂ above 50 mmHg); pulmonary hypertension or cor pulmonale despite oxygen therapy; or 3+ acute exacerbations per year. Referral for evaluation (not necessarily immediate listing) is recommended at BODE 5–6 to allow time for the evaluation process. Eligibility requirements: typically age below 65; non-smoking (ideally 6+ months); adequate cardiac, renal, and liver function; BMI 17–35; strong psychosocial support. Transplant substantially improves quality of life and in selected patients improves survival. All referral and management decisions require specialist physician evaluation.

Sources & Methodology

Celli, B.R. et al. (2004). The Body-Mass Index, Airflow Obstruction, Dyspnea, and Exercise Capacity Index in COPD. NEJM, 350(10), 1005–1012. GOLD (2023). Global Strategy for Diagnosis, Management, Prevention of COPD.

How helpful was this calculator?

Be the first to rate!

Related Calculators

Gas Bill Calculator

Home & Living Calculators

Cholesterol Ratio Calculator

Lipid & Cholesterol Calculators

Tidal Volume Calculator

Pulmonology & Respiratory Calculators

Serum Osmolality Calculator

Dialysis & Electrolyte Calculators

Glasgow-Blatchford Bleeding Score

Pancreas & Gastroenterology

Carboplatin AUC Calculator

Pharmacology & Drug Dosing Calculators